Search research articles
Contact Us
Filters
Showing results (101-110 of 207) with videos related to
Page
of 21
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2024
Patient-reported disability progression outcomes among patients with multiple sclerosis: Results of an outcomes-based agreement
Elizabeth C S Swart, Samuel K Peasah, Jacqueline Alderson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 13, 2019
Adverse drug reactions in the Veterans Affairs healthcare system: Frequency, severity, and causative medications analyzed by patient age
Von R Moore, Peter A Glassman, Anthony Au, et al.
Medical Care
|
June 14, 2011
Potential safety gaps in order entry and automated drug alerts: a nationwide survey of VA physician self-reported practices with computerized order entry
Jeffrey R Spina, Peter A Glassman, Barbara Simon, et al.
JAMA Internal Medicine
|
November 11, 2014
Dual use of Department of Veterans Affairs and medicare benefits and use of test strips in veterans with type 2 diabetes mellitus
Walid F Gellad, Xinhua Zhao, Carolyn T Thorpe, et al.
JAMA Neurology
|
August 27, 2019
Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D
Alvaro San-Juan-Rodriguez, Chester B Good, Rock A Heyman, et al.
Military Medicine
|
February 7, 2008
Determinants of hormone therapy discontinuation among female veterans nationally
Sally G Haskell, Bevanne Bean-Mayberry, Joseph L Goulet, et al.
Journal of Managed Care & Specialty Pharmacy
|
August 30, 2025
Impact of a real-time prescription benefit on adherence and utilization of low-cost prescription alternatives for members new to diabetes treatment
Elizabeth C S Swart, Jennifer L Nguyen, Samuel K Peasah, et al.
American Journal of Public Health
|
March 3, 2007
Symptom expression in coronary heart disease and revascularization recommendations for black and white patients
Marilyn Hravnak, Jeff Whittle, Mary E Kelley, et al.
Gut
|
September 29, 2006
Rate and predictors of treatment prescription for hepatitis C
Adeel A Butt, Amy C Justice, Melissa Skanderson, et al.
The American Journal of Managed Care
|
December 6, 2013
FDA warning and removal of rosiglitazone from VA national formulary
Sherrie E Aspinall, Xinhua Zhao, Chester B Good, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 207) with videos related to
Sort By:
Page
of 21
Journal of Managed Care & Specialty Pharmacy
|
October 29, 2024
Patient-reported disability progression outcomes among patients with multiple sclerosis: Results of an outcomes-based agreement
Elizabeth C S Swart, Samuel K Peasah, Jacqueline Alderson, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
February 13, 2019
Adverse drug reactions in the Veterans Affairs healthcare system: Frequency, severity, and causative medications analyzed by patient age
Von R Moore, Peter A Glassman, Anthony Au, et al.
Medical Care
|
June 14, 2011
Potential safety gaps in order entry and automated drug alerts: a nationwide survey of VA physician self-reported practices with computerized order entry
Jeffrey R Spina, Peter A Glassman, Barbara Simon, et al.
JAMA Internal Medicine
|
November 11, 2014
Dual use of Department of Veterans Affairs and medicare benefits and use of test strips in veterans with type 2 diabetes mellitus
Walid F Gellad, Xinhua Zhao, Carolyn T Thorpe, et al.
JAMA Neurology
|
August 27, 2019
Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D
Alvaro San-Juan-Rodriguez, Chester B Good, Rock A Heyman, et al.
Military Medicine
|
February 7, 2008
Determinants of hormone therapy discontinuation among female veterans nationally
Sally G Haskell, Bevanne Bean-Mayberry, Joseph L Goulet, et al.
Journal of Managed Care & Specialty Pharmacy
|
August 30, 2025
Impact of a real-time prescription benefit on adherence and utilization of low-cost prescription alternatives for members new to diabetes treatment
Elizabeth C S Swart, Jennifer L Nguyen, Samuel K Peasah, et al.
American Journal of Public Health
|
March 3, 2007
Symptom expression in coronary heart disease and revascularization recommendations for black and white patients
Marilyn Hravnak, Jeff Whittle, Mary E Kelley, et al.
Gut
|
September 29, 2006
Rate and predictors of treatment prescription for hepatitis C
Adeel A Butt, Amy C Justice, Melissa Skanderson, et al.
The American Journal of Managed Care
|
December 6, 2013
FDA warning and removal of rosiglitazone from VA national formulary
Sherrie E Aspinall, Xinhua Zhao, Chester B Good, et al.
Page
of 21